Although increased SSBP2 expression was associated with shorter survival in glioblastoma [45], SSBP2 was also shown to inhibit the growth of prostate cancer cells [46] and to act as a tumor suppressor in myeloid leukemias [21]. The gene discussed is SSBP2; the disease is prostate carcinoma.